Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Tada

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
International Journal of Oncology|April 17, 2018
Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomasToshiyuki Sumi, Sachie Hirai, Miki Yamaguchi, et al.
Surgery Today|September 9, 2022
Number of lymph nodes dissected and upstaging rate of the N factor in robot-assisted thoracic surgery versus video-assisted thoracic surgery for patients with cN0 primary lung cancerYuma Shindo, Masahiro Miyajima, Yasuyuki Nakamura, et al.
Biochemical and Biophysical Research Communications|April 24, 2017
Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinomaMiki Yamaguchi, Sachie Hirai, Toshiyuki Sumi, et al.
Surgery Today|July 23, 2025
Long-term survival outcome after surgical resection of pulmonary neuroendocrine tumorsEisuke Goto, Keiju Aokage, Kotaro Nomura, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
International Journal of Oncology|April 17, 2018
Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomasToshiyuki Sumi, Sachie Hirai, Miki Yamaguchi, et al.
Surgery Today|September 9, 2022
Number of lymph nodes dissected and upstaging rate of the N factor in robot-assisted thoracic surgery versus video-assisted thoracic surgery for patients with cN0 primary lung cancerYuma Shindo, Masahiro Miyajima, Yasuyuki Nakamura, et al.
Biochemical and Biophysical Research Communications|April 24, 2017
Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinomaMiki Yamaguchi, Sachie Hirai, Toshiyuki Sumi, et al.
Surgery Today|July 23, 2025
Long-term survival outcome after surgical resection of pulmonary neuroendocrine tumorsEisuke Goto, Keiju Aokage, Kotaro Nomura, et al.
Pageof 4